[go: up one dir, main page]

WO2005051316A3 - Compositions a base de polymeres et leurs procedes d'utilisation - Google Patents

Compositions a base de polymeres et leurs procedes d'utilisation Download PDF

Info

Publication number
WO2005051316A3
WO2005051316A3 PCT/US2004/039491 US2004039491W WO2005051316A3 WO 2005051316 A3 WO2005051316 A3 WO 2005051316A3 US 2004039491 W US2004039491 W US 2004039491W WO 2005051316 A3 WO2005051316 A3 WO 2005051316A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
methods
polymer compositions
prevention
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2004/039491
Other languages
English (en)
Other versions
WO2005051316A2 (fr
Inventor
William L. Hunter
David M. Gravett
Philip M. Toleikis
Arpita Maiti
Richard T. Liggins
Aniko Takacs-Cox
Rui Avelar
Troy A. E. Loss
Dechi Guan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angiotech International AG
Original Assignee
Angiotech International AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/986,231 external-priority patent/US20050181977A1/en
Application filed by Angiotech International AG filed Critical Angiotech International AG
Publication of WO2005051316A2 publication Critical patent/WO2005051316A2/fr
Anticipated expiration legal-status Critical
Publication of WO2005051316A3 publication Critical patent/WO2005051316A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Surgery (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention a trait à des compositions comportant des agents anti-fibrotiques et/ou des compositions polymériques utilisées dans diverses applications médicales comprenant la prévention d'adhérences chirurgicales, le traitement de l'arthrite inflammatoire, le traitement de cicatrices et de chéloïdes, le traitement de maladie vasculaire, et la prévention de la perte cartilagineuse.
PCT/US2004/039491 2003-11-20 2004-11-22 Compositions a base de polymeres et leurs procedes d'utilisation Ceased WO2005051316A2 (fr)

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
US52390803P 2003-11-20 2003-11-20
US60/523,908 2003-11-20
US52522603P 2003-11-24 2003-11-24
US60/525,226 2003-11-24
US52654103P 2003-12-03 2003-12-03
US60/526,541 2003-12-03
US56656904P 2004-04-28 2004-04-28
US60/566,569 2004-04-28
US58686104P 2004-07-09 2004-07-09
US60/586,861 2004-07-09
US61107704P 2004-09-17 2004-09-17
US60/611,077 2004-09-17
US10/986,231 2004-11-10
US10/986,231 US20050181977A1 (en) 2003-11-10 2004-11-10 Medical implants and anti-scarring agents

Publications (2)

Publication Number Publication Date
WO2005051316A2 WO2005051316A2 (fr) 2005-06-09
WO2005051316A3 true WO2005051316A3 (fr) 2010-01-28

Family

ID=34637499

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2004/039389 Ceased WO2005051452A2 (fr) 2003-11-20 2004-11-22 Compositions a base de polymeres et leurs procedes d'utilisation
PCT/US2004/039491 Ceased WO2005051316A2 (fr) 2003-11-20 2004-11-22 Compositions a base de polymeres et leurs procedes d'utilisation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/US2004/039389 Ceased WO2005051452A2 (fr) 2003-11-20 2004-11-22 Compositions a base de polymeres et leurs procedes d'utilisation

Country Status (6)

Country Link
EP (1) EP1684819A2 (fr)
JP (1) JP2007517543A (fr)
AU (1) AU2004293071A1 (fr)
CA (1) CA2536181A1 (fr)
IL (1) IL174641A0 (fr)
WO (2) WO2005051452A2 (fr)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006511475A (ja) 2002-09-18 2006-04-06 トラスティーズ オブ ザ ユニバーシティ オブ ペンシルベニア 脈絡膜新生血管症の抑制方法
WO2005027906A1 (fr) 2003-09-18 2005-03-31 Macusight, Inc. Administration transsclerale d'agents therapeutiques
WO2005049105A2 (fr) * 2003-11-10 2005-06-02 Angiotech International Ag Implants medicaux et agents anti-cicatrisation
GB2438544A (en) 2005-02-09 2007-11-28 Cooper Internat Corp Liquid formulations for treatment of diseases or conditions
US8663639B2 (en) 2005-02-09 2014-03-04 Santen Pharmaceutical Co., Ltd. Formulations for treating ocular diseases and conditions
JP4967136B2 (ja) * 2005-06-24 2012-07-04 国立大学法人 東京医科歯科大学 薬剤溶出性ステント
JP2007135965A (ja) * 2005-11-21 2007-06-07 Tohoku Univ 体内留置多機能ステントおよびその製造方法
CA2635797C (fr) 2006-02-09 2015-03-31 Macusight, Inc. Formulations stables et leurs procedes de preparation et d'utilisation
CN101443004B (zh) 2006-03-23 2013-03-06 参天制药株式会社 用于与血管通透性有关的疾病或病症的制剂
EP3009477B1 (fr) 2006-07-20 2024-01-24 Orbusneich Medical Pte. Ltd Composition polymère bioabsorbable pour un dispositif médical
EP2073754A4 (fr) 2006-10-20 2012-09-26 Orbusneich Medical Inc Composition polymère bioabsorbable et fond de dispositif médical
US7959942B2 (en) 2006-10-20 2011-06-14 Orbusneich Medical, Inc. Bioabsorbable medical device with coating
US9023114B2 (en) 2006-11-06 2015-05-05 Tyrx, Inc. Resorbable pouches for implantable medical devices
JP5398535B2 (ja) * 2006-11-06 2014-01-29 タイレックス・インコーポレイテッド 埋込型医療機器のための吸収性パウチ
US7801624B1 (en) 2007-01-16 2010-09-21 Pacesetter, Inc. Reduced perforation distal tip for an implantable cardiac electrotherapy lead
US11197651B2 (en) 2007-03-08 2021-12-14 Sync-Rx, Ltd. Identification and presentation of device-to-vessel relative motion
US9375164B2 (en) 2007-03-08 2016-06-28 Sync-Rx, Ltd. Co-use of endoluminal data and extraluminal imaging
US11064964B2 (en) 2007-03-08 2021-07-20 Sync-Rx, Ltd Determining a characteristic of a lumen by measuring velocity of a contrast agent
US8700130B2 (en) 2007-03-08 2014-04-15 Sync-Rx, Ltd. Stepwise advancement of a medical tool
US9968256B2 (en) 2007-03-08 2018-05-15 Sync-Rx Ltd. Automatic identification of a tool
WO2010058398A2 (fr) 2007-03-08 2010-05-27 Sync-Rx, Ltd. Traitement d'image et activation d'outil pour procédures médicales
WO2008107905A2 (fr) 2007-03-08 2008-09-12 Sync-Rx, Ltd. Imagerie et outils à utiliser avec des organes mobiles
US10716528B2 (en) 2007-03-08 2020-07-21 Sync-Rx, Ltd. Automatic display of previously-acquired endoluminal images
US9629571B2 (en) 2007-03-08 2017-04-25 Sync-Rx, Ltd. Co-use of endoluminal data and extraluminal imaging
US8455459B2 (en) * 2007-08-02 2013-06-04 Medicis Pharmaceutical Corporation Method of applying an injectable filler
CA2730995C (fr) * 2008-07-17 2016-11-22 Micell Technologies, Inc. Dispositif medical d'administration de medicament
US8039433B2 (en) * 2008-08-19 2011-10-18 Warsaw Orthopedic, Inc. Osteogenic compositions containing a coloring agent
US9095313B2 (en) 2008-11-18 2015-08-04 Sync-Rx, Ltd. Accounting for non-uniform longitudinal motion during movement of an endoluminal imaging probe
US9101286B2 (en) 2008-11-18 2015-08-11 Sync-Rx, Ltd. Apparatus and methods for determining a dimension of a portion of a stack of endoluminal data points
US8855744B2 (en) 2008-11-18 2014-10-07 Sync-Rx, Ltd. Displaying a device within an endoluminal image stack
US9974509B2 (en) 2008-11-18 2018-05-22 Sync-Rx Ltd. Image super enhancement
US10362962B2 (en) 2008-11-18 2019-07-30 Synx-Rx, Ltd. Accounting for skipped imaging locations during movement of an endoluminal imaging probe
US9144394B2 (en) 2008-11-18 2015-09-29 Sync-Rx, Ltd. Apparatus and methods for determining a plurality of local calibration factors for an image
US11064903B2 (en) 2008-11-18 2021-07-20 Sync-Rx, Ltd Apparatus and methods for mapping a sequence of images to a roadmap image
HUP1000385A2 (en) 2010-07-21 2012-01-30 Medicontur Orvostechnikai Kft Alkane diol derivatives preparation thereof and based on them
WO2012048298A2 (fr) 2010-10-08 2012-04-12 Caridianbct, Inc. Procédés et systèmes de culture et de récolte de cellules dans un système de bioréacteur à fibres creuses avec conditions de régulation
ES2537411T3 (es) 2011-04-20 2015-06-08 Carbylan Therapeutics, Inc. Composiciones formadoras de gel in situ
EP2723231A4 (fr) 2011-06-23 2015-02-25 Sync Rx Ltd Nettoyage d'arrière-plan luminal
EP2734261B1 (fr) 2011-07-18 2018-02-21 Mor-Research Applications Ltd. Dispositif pour l'ajustement de la tension intraoculaire
WO2013063585A1 (fr) * 2011-10-28 2013-05-02 Baxter International Inc. Compositions aqueuses pour l'hémostase osseuse, et procédés pour leur utilisation et leur fabrication
EP2863802B1 (fr) 2012-06-26 2020-11-04 Sync-RX, Ltd. Traitement d'image lié au flux dans les organes luminaux
AU2014252769B2 (en) 2013-04-10 2017-11-30 The University Of Melbourne Biodegradable network polymers for regenerative medicine and tissue engineering
WO2015073918A1 (fr) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expansion de cellules dans un bioréacteur
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
WO2016049421A1 (fr) 2014-09-26 2016-03-31 Terumo Bct, Inc. Alimentation programmée
WO2017004592A1 (fr) 2015-07-02 2017-01-05 Terumo Bct, Inc. Croissance cellulaire à l'aide de stimuli mécaniques
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11096781B2 (en) 2016-08-01 2021-08-24 Edwards Lifesciences Corporation Prosthetic heart valve
US11629332B2 (en) 2017-03-31 2023-04-18 Terumo Bct, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
CN108498905B (zh) * 2018-04-03 2024-08-06 广州迈普再生医学科技股份有限公司 用于双联混合注射器的腔镜型喷头及腔镜型双联混合注射器
HUE067442T2 (hu) 2017-11-09 2024-10-28 Convatec Technologies Inc Sztómafigyelõ rendszer
WO2020030486A1 (fr) * 2018-08-09 2020-02-13 Gambro Lundia Ab Procédé de détection de l'obstruction d'écoulement dans un circuit extracorporel, appareil et programme informatique
USD893514S1 (en) 2018-11-08 2020-08-18 11 Health And Technologies Limited Display screen or portion thereof with graphical user interface
US20200254103A1 (en) * 2019-02-11 2020-08-13 John Mee Method for treating neurological conditions and improving human cognition
BR112023002487A2 (pt) 2020-08-24 2023-05-02 Edwards Lifesciences Corp Cobertura de balão para um aparelho de distribuição para uma válvula cardíaca protética expansível
JP2023545504A (ja) 2020-10-15 2023-10-30 コンバテック・テクノロジーズ・インコーポレイテッド オストミーシステムおよび方法
GB2619893A (en) 2021-03-23 2023-12-20 Terumo Bct Inc Cell capture and expansion
CN113281317B (zh) * 2021-05-14 2022-04-29 北京指真生物科技有限公司 一种含有花菁类化合物的编码微球及其制备方法和应用
US12209689B2 (en) 2022-02-28 2025-01-28 Terumo Kabushiki Kaisha Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device
CN115382028A (zh) * 2022-09-19 2022-11-25 郑州大学第一附属医院 一种可降解吻合器材料及其制备方法和应用
WO2024159015A1 (fr) * 2023-01-25 2024-08-02 North Carolina State University Compositions et méthodes se rapportant à des compositions thérapeutiques inhalables
JP7602090B1 (ja) * 2024-06-10 2024-12-17 真由美 大石 生体組織の瘢痕化を抑制するための創傷用足場材
CN118903564B (zh) * 2024-09-02 2025-11-04 嘉兴睿清医疗科技有限公司 一种羟基磷灰石复合聚酯微球及其制备方法和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050175665A1 (en) * 2003-11-20 2005-08-11 Angiotech International Ag Polymer compositions and methods for their use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6730313B2 (en) * 2000-01-25 2004-05-04 Edwards Lifesciences Corporation Delivery systems for periadventitial delivery for treatment of restenosis and anastomotic intimal hyperplasia
WO2002087563A2 (fr) * 2001-05-01 2002-11-07 Angiotech Pharmaceuticals Inc. Compositions et procedes pour le traitement d'etats inflammatoires par des proteines ou polysaccharides contenant des agents anti-microtubules
US20030207907A1 (en) * 2002-05-03 2003-11-06 Iversen Patrick L. Delivery of microparticle-conjugated drugs for inhibition of stenosis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050175665A1 (en) * 2003-11-20 2005-08-11 Angiotech International Ag Polymer compositions and methods for their use

Also Published As

Publication number Publication date
CA2536181A1 (fr) 2005-06-09
WO2005051452A2 (fr) 2005-06-09
IL174641A0 (en) 2006-08-20
JP2007517543A (ja) 2007-07-05
EP1684819A2 (fr) 2006-08-02
WO2005051316A2 (fr) 2005-06-09
AU2004293071A1 (en) 2005-06-09

Similar Documents

Publication Publication Date Title
WO2005051316A3 (fr) Compositions a base de polymeres et leurs procedes d'utilisation
WO2007041593A3 (fr) Associations de medicaments empechant la formation de cicatrices et leur utilisation
WO2006135479A3 (fr) Agents anti-cicatrisation, compositions therapeutiques, et leurs utilisations
PT1420801E (pt) Utilização de fucanos no tratamento de adesões, artrite e psoríase
WO2003087254A3 (fr) Compositions adhesives hydrophiles
EP2497478A3 (fr) Composition d'oligosaccarides et leur utilisation dans le traitement d'infection
WO2002041837A3 (fr) Traitement de mucosite
WO2005016256A3 (fr) Compositions hemostatiques contenant de la thrombine sterile
DE502004007577D1 (en) Lymerpartikel
DK1721623T3 (da) Absorberende polymersammensætninger, medicinske artikler og fremgangsmåder
WO2004108093A3 (fr) Compositions antiseptiques, prodedes et systemes associes
EP1699397A4 (fr) Ensembles, systemes et procedes destines a des pansements en tissu formes a partir de structures spongieuses polymeres hydrophiles telles qu'un chitosane
WO2009081408A3 (fr) Caillots de fibrine pulvérisés et compositions pharmaceutiques les contenant
WO2002098477A3 (fr) Modificateurs de surfaces bioactifs destines a des polymeres et a des articles fabriques a partir de polymeres
PT1315771E (pt) Material biologicamente activo
WO2006110197A3 (fr) Dispositif medical en polymere biodegradable
WO2002064189A3 (fr) Hydrogels reticules par rayonnements
WO2006132647A3 (fr) Copolymeres antimicrobiens et leurs utilisations
WO2009029049A8 (fr) Composition de ciment osseux ou dentaire et ses utilisations
GB2430157A (en) Personal care products and methods for inhibiting the adherence of flora to skin
GB2451599A (en) Nanostructures suitable for delivery of agents
WO2007056134A3 (fr) Polymeres phenoliques resorbables
WO2008021548A3 (fr) Poly(ester amides) contenant des époxy et procédés d'utilisation
WO2008153762A3 (fr) Formulations s-nitrosothiol et systèmes d'entreposage
PL2347723T3 (pl) Urządzenie do anastomozy

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200480033522.6

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWE Wipo information: entry into national phase

Ref document number: 1696/KOLNP/2006

Country of ref document: IN

122 Ep: pct application non-entry in european phase